What The Study Did: The characteristics and expected strength of evidence of COVID-19 studies registered on ClinicalTrials.gov are evaluated in this observational study.
Authors: Mintu Turakhia, M.D., M.A.S., of the Stanford University School of Medicine in Palo Alto, California, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2020.2904)
Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
Media advisory: The full study and editorial are linked to this news release.Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.2904?guestAccessKey=68622861-c5c6-4dff-9745-ee30ac938b01&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072720
###
Journal
JAMA Internal Medicine